U.S. markets closed

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
4.2400+0.0400 (+0.95%)
Al cierre: 04:00PM EDT
4.2400 0.00 (0.00%)
Fuera de horario: 04:02PM EDT

Harvard Bioscience, Inc.

84 October Hill Road
Suite 10
Holliston, MA 01746
United States
508 893 8999
https://www.harvardbioscience.com

Sector(es)Healthcare
IndustriaMedical Instruments & Supplies
Empleados a tiempo completo391

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. James W. GreenPresident, CEO & Chairman607.35kN/D1958
Ms. Jennifer Cote CPA, CGMACFO & TreasurerN/DN/DN/D
Mr. David BalcomSenior Vice President of OperationsN/DN/DN/D
Mr. John J. FryChief Legal Counsel & Corporation SecretaryN/DN/D1961
Mr. Ryan WallaceSenior Vice President of Global SalesN/DN/DN/D
Ms. Lori PackerVice President of Global People OperationsN/DN/DN/D
David SiroisDirector of Corporate Accounting & SEC ReportingN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Gestión corporativa

La calificación ISS Governance QuickScore de Harvard Bioscience, Inc. a partir del 1 de marzo de 2024 es 5. Las puntuaciones principales son Auditoría: 8; Junta: 7; Derechos del accionista: 7; Compensación: 1.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.